Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma [Phase 3]
A Phase 3 trial is recruiting to compare tunlametinib capsules with combination chemotherapy in adults with advanced NRAS-mutant melanoma.
-
CLINICAL_TRIALS trial_result · 2024-06-26Clinical Trial Update: PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of PF-06952229 in adults with advanced solid tumors was terminated. Results were posted on 2024-06-26.
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: PET/CT Whole-body Dynamic Acquisition at FDG to Metastatic Melanoma Under Immunotherapy
This trial evaluates whole-body dynamic PET/CT imaging with FDG to assess metastatic melanoma in patients undergoing immunotherapy.
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: LATe TreatmENT Related Toxicity in Melanoma (LATENT)
Clinical trial update for LATe TreatmENT Related Toxicity in Melanoma (LATENT) sponsored by Royal Marsden NHS Foundation Trust. The study fo…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors [Phase 2, Phase 3]
Clinical trial update for a Phase 2/Phase 3 study examining trans-arterial/intra-tumor infusion of checkpoint inhibitors plus chemotherapy f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid Tumors [Phase 1]
Phase 1 safety study evaluating encorafenib in Chinese patients with advanced/metastatic BRAF V600E-mutant solid tumors, including melanoma …
-
CLINICAL_TRIALS research · 2024-06-24Clinical Trial Update: Circulating Tumour DNA Guided Adaptive BRAF and MEK Inhibitor Therapy [Phase 2]
Phase 2 trial evaluating circulating tumor DNA–guided adaptive therapy using BRAF and MEK inhibitors for melanoma; status is not yet recruit…
-
CLINICAL_TRIALS trial_result · 2024-06-24Clinical Trial Update: Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors
A completed clinical trial comparing three in vivo microscopic imaging techniques for diagnosing pigmented skin tumors conducted by Centre H…
-
CLINICAL_TRIALS other · 2024-06-21Clinical Trial Update: Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for EOS-448 in combination with standard of care or investigational therapies in advanced solid tumors, including lung…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Melanoma
A completed clinical trial focusing on establishing and standardizing a platform for in-depth tumor profiling in patients with melanoma.
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Dermoscopy Augmented Histology Trial, Consensus Agreement Diagnosis Made by Dermatopathology Experts
This ClinicalTrials.gov entry describes an ongoing study evaluating Dermoscopy Augmented Histology to support consensus diagnoses by dermato…
-
CLINICAL_TRIALS other · 2024-06-17Clinical Trial Update: Dermoscopy Augmented Histology Trial, a Randomized Controlled Trial [NA]
Clinical trial update for a randomized Dermoscopy-augmented histology study in melanoma and pigmented lesions; the study is currently not ye…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: RATIO: Rational Approach To Immuno-Oncology [NA]
A clinical trial update for the RATIO study on immuno-oncology in metastatic melanoma indicates the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of ADCT-301 in Patients With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial update for ADCT-301 (camidanlumab tesirine) in selected advanced solid tumors; the study has been terminated and results have …
-
CLINICAL_TRIALS research · 2024-06-13Clinical Trial Update: Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
This clinical trial update describes a retrospective analysis of a drug-metabolizing genotype in cancer patients and analyzes correlations w…
-
CLINICAL_TRIALS trial_result · 2024-06-10Clinical Trial Update: Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients [NA]
This clinical trial update reports the completion of a study evaluating sphingolipids as predictive biomarkers for response to immune checkp…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Sequential Combo Immuno and Target Therapy (SECOMBIT) Study [Phase 2]
The SECOMBIT Phase 2 trial in metastatic melanoma has completed, evaluating sequential immunotherapy and targeted therapy.
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention [Phase 1]
Phase 1 trial evaluating a gut microbiome intervention in patients with metastatic melanoma to explore effects on checkpoint-related respons…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors [NA]
A clinical trial is validating an immunological functional test to predict how metastatic melanoma patients will respond to checkpoint inhib…
-
CLINICAL_TRIALS trial_result · 2024-06-03Clinical Trial Update: Pattern of Use and Safety/Effectiveness of Nivolumab in Routine Oncology Practice
Real-world data on the use, safety, and effectiveness of nivolumab in melanoma and lung cancer from routine oncology practice.
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates for the First Prescription of Targeted Therapies [NA]
A clinical trial update describes a telenursing program to monitor supportive care needs in patients with lung cancer or melanoma who are ca…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies [Phase 1]
This Phase 1 trial evaluated the safety and tolerability of immunotherapy combinations across multiple advanced cancers and has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma [Phase 1, Phase 2]
A Phase 1/2 study evaluating safety and efficacy of encorafenib with or without binimetinib in combination with nivolumab and low-dose ipili…
-
CLINICAL_TRIALS other · 2024-05-23Clinical Trial Update: Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma [Phase 3]
Phase 3 adjuvant trial of nivolumab for high-risk Stage II melanoma is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma [Phase 1]
A Phase 1 clinical trial update describing AK104 or AK112 in combination with Axitinib for metastatic mucosal melanoma, currently not yet re…